21-hydroxylase deficiency risk factors: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
The most potent risk factor in the development of 21-hydroxylase deficient congenital adrenal hyperplasia is [[Mutation]]s in the ''CYP21A2'' gene. | The most potent risk factor in the development of 21-hydroxylase deficient [[congenital adrenal hyperplasia]] is [[Mutation]]s in the ''CYP21A2'' gene. | ||
==Risk Factors== | ==Risk Factors== | ||
[[Mutation]]s in the ''CYP21A2'' gene cause 21-hydroxylase deficient congenital adrenal hyperplasia. | [[Mutation]]s in the ''CYP21A2'' gene cause 21-hydroxylase deficient congenital adrenal hyperplasia. | ||
Revision as of 13:52, 16 September 2015
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency risk factors |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
Risk calculators and risk factors for 21-hydroxylase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
The most potent risk factor in the development of 21-hydroxylase deficient congenital adrenal hyperplasia is Mutations in the CYP21A2 gene.
Risk Factors
Mutations in the CYP21A2 gene cause 21-hydroxylase deficient congenital adrenal hyperplasia.